The financials
Generate Biomedicines, Inc. by the numbers
Generate Biomedicines, Inc. (GENB) reported revenue of $6.3M in Q2 2026 (quarter ended June 30, 2026), down 28% from the same quarter a year earlier. That came with net loss of $67M.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $6.3M | $8.8M | −28% |
| Operating income | −$72M | −$48M | n/a |
| Net income | −$67M | −$42M | n/a |
| Diluted EPS | −$0.52 | −$1.62 | n/a |
Biotechnology
The closest names by size in the same industry